Recombinant Human herpesvirus 2 Envelope glycoprotein I (gI)

What is the molecular composition and function of HSV-2 glycoprotein I?

HSV-2 glycoprotein I (gI) is encoded by the US7 gene and functions primarily as part of a heterodimeric complex with glycoprotein E (gE). This complex serves multiple critical functions in HSV-2 pathogenesis:

• In epithelial cells, the gE/gI heterodimer is required for cell-to-cell spread of the virus by sorting nascent virions to cell junctions

• In neuronal cells, gE/gI is essential for the anterograde spread of infection throughout the host nervous system

• Together with US9, the heterodimer facilitates sorting and transport of viral structural components toward axon tips

• The heterodimer serves as a receptor for the Fc domain of human IgG, with dissociation occurring at acidic pH

The heterodimer plays a significant role in immune evasion through a process called antibody bipolar bridging, followed by intracellular endocytosis and degradation, which interferes with host Ig-mediated immune responses .

How does the genetic organization of the US7 region relate to gI expression?

The HSV-2 US7 gene encoding gI is located in the unique short (US) region of the viral genome, adjacent to the US8 gene encoding gE. When amplified for research purposes, a common approach is to generate a fragment spanning from 57 bp upstream of the US7 start codon to include its regulatory elements . The genomic organization is as follows:

PCR amplification of this region typically yields a 3,182-bp segment that includes the complete US7 gene, the intergenic region, and the US8 gene .

What are optimal expression systems for producing functional recombinant HSV-2 gI?

Several expression systems have been successfully employed for producing recombinant HSV-2 gI, each with distinct advantages:

Eukaryotic baculovirus expression system:
The baculovirus/Spodoptera frugiperda (Sf9) expression system has proven highly effective for producing glycoproteins in their properly folded and post-translationally modified forms. Research indicates that high-density cell culture optimization can significantly improve yields:

Under these optimized conditions, Sf9 cell density can reach 9.6×10^6 cells/mL with recombinant glycoprotein yields up to 192 mg/L .

Mammalian cell expression:
For studies requiring authentic glycosylation patterns that closely mimic those in human infection, mammalian expression systems (HEK293, CHO) are preferred. When co-expressing gI with gE, a vector design incorporating a strong promoter (such as CMV) for each gene, separated by an IRES element or using separate vectors, provides better heterodimer formation .

What methodologies are most effective for analyzing gE/gI heterodimer formation and Fc-binding activity?

Surface Plasmon Resonance (SPR):
SPR has been established as the gold standard for studying protein-protein interactions between gE/gI and IgG Fc domains. Key methodological considerations include:

Research has demonstrated that while soluble gE-2 alone is incapable of binding human IgG or the IgG Fc domain, co-expression with gI-2 and purification of the gE-2/gI-2 heterodimer enables binding to human IgG through its Fc domain .

Size Exclusion Chromatography (SEC):
SEC combined with multi-angle light scattering (SEC-MALS) provides valuable information about heterodimer formation, stoichiometry, and stability. Typical running conditions include:

• Buffer: PBS pH 7.4

• Flow rate: 0.5 mL/min

• Detection: UV absorbance at 280 nm coupled with light scattering

What amino acid residues are critical for gI function and heterodimer formation?

Research using site-directed mutagenesis has identified several key regions in both gI and gE that are critical for heterodimer formation and Fc binding:

Interestingly, gE-2 mutants with reduced Fc binding capacity maintain the ability to form heterodimers with gI, indicating that these functions are structurally distinct .

How does recombinant gI distribution on virions contribute to the fusion and entry process?

Super-resolution microscopy studies have revealed important insights into glycoprotein distribution on HSV virions:

• Most glycoproteins, including gB, gH/gL, and gC are distributed evenly around purified virions

• In contrast, glycoprotein distribution patterns change significantly upon cell binding

• This redistribution of glycoproteins upon cell attachment may contribute to initiating the cascade of activations leading to membrane fusion

While these studies primarily examined HSV-1, they provide valuable methodological approaches that can be applied to studying HSV-2 gI distribution:

• Purify virions through sucrose gradient ultracentrifugation

• Label using specific antibodies against gI and other glycoproteins

• Analyze using super-resolution techniques like STORM or PALM

• Compare glycoprotein distribution patterns between cell-free and cell-bound virions

How does genetic diversity in HSV-2 gI compare to other viral glycoproteins?

Phylogenetic analyses of HSV-2 glycoproteins have revealed important patterns of diversity:

This differential evolutionary rate between gI and gE suggests that gI function is more tightly constrained during viral evolution.

What methods are most effective for detecting recombination events in genes encoding HSV-2 gI?

Several complementary computational approaches have been used to detect recombination in HSV-2 genes:

While HSV-2 generally shows less evidence of recombination than HSV-1, recombination has been detected within continents and much less frequently between continents in both strains .

How can recombinant HSV-2 gI/gE heterodimers be utilized for vaccine development?

The gE/gI heterodimer represents a promising vaccine target, but its Fc-binding activity can potentially mask functional epitopes and affect its immunogenicity. Research has shown that:

• A series of gE-2 mutations within the surface-exposed Fc:gE-2 interface can abrogate or reduce Fc binding while maintaining heterodimer formation with gI

• Vaccinating with Fc-binding deficient gE-2/gI-2 heterodimers elicited comparable anti-heterodimer binding antibody titers and statistically significantly higher serum neutralization antibody levels than wildtype heterodimers

Methodological approach for designing improved gE/gI-based vaccines:

• Design mutations in gE-2 based on structural knowledge of the Fc:gE-2 interface

• Co-express mutant gE-2 with wildtype gI-2

• Evaluate heterodimer formation and Fc binding by SPR

• Assess immunogenicity in animal models measuring both binding and neutralizing antibodies

What are the challenges in developing diagnostic tests based on HSV-2 gI?

Diagnostic tests using HSV glycoproteins face several challenges:

• Some serological tests fail to differentiate HSV-1 from HSV-2, especially in East Africa, with specificity as low as 50.7%

• Sequences from African HSV-2 isolates contain unique amino acid signatures in glycoproteins G, I, and E, which may account for the failure of sensitive antibody tests

Consensus sequences generated from diverse global populations can be used to improve diagnostic assays that differentiate HSV-1 from HSV-2 . When developing gI-based diagnostics, researchers should:

• Include sequences from multiple geographic regions in antigen design

• Focus on conserved epitopes that show minimal variation across isolates

• Consider using multiple glycoproteins (combination of gG, gI, and gE) to improve specificity

• Validate assays against genetically diverse clinical isolates

This approach would help address the challenges posed by geographic variations in HSV-2 sequences.